Back to homepage

KEY REFERENCES FOR DOSE-EFFECT ANALYSIS FROM CHOU ET AL

Cite-Track and More Recent Publications (http://www.researcherid.com/rid/B-4111-2009) and Ting-Chao Chou - Google Scholar Citations)[Updated 12/31/2015]

  1. For Highly Cited Applications of CI Method Co-Authored by T.C. Chou:

    JNCI 86: 11517-1524, 1994 (Cited 441 times in 121 journals).

    J Clin Oncol 14: 709-715, 1996 (Cited 365 times in 89 journals) for Anti-cancer agents combinations (with crude data illustrations)

    Nature Med 6: 200-206, 2000 (Cited 840 times in 147 journals) (Up to 4 mAbs combos)

    Science 236: 1376-1379, 1997 (Cited 310 times in 105 journals) (for Anti_HIV combos)

    Antiviral Agent Chemother 31: 168-172, 1987 (Cited 206 times in 115 journals) (for Anti-HIV combos)

    Transplantation 51: 232-238, 1991 (Cited 206 times in 77 journals) (for Immunosuppresants combos)
  2. For Clinical Drug Combination Review:
    • Chou, T.-C. Preclinical Versus Clinical Drug Combination Studies. Leukemia & Lymphoma 49: 2059-2080, 2008 (A Review; with sample computer printout)

    Integrative Biol 3: 548-559, 2011 (A Perspective article featured on the front cover in May 2011 issue)
  3. The FAQ Article:

    • Chou, T.-C. Drug Combination Studies and their Synergism Quantification Using Chou-Talalay Method. Cancer Research 70: 440-446, 2010 (01/15/2010. (A Perspective Article focusing on common errors, pitfalls, and most frequently asked questions in drug combination studies) [Cited 808 times since 2010]

    • Chou T.-C. Am J Cancer Res 1: 925-954, 2011 (A 30-page Review Article, see p.945, Table 5)

    • Chou, T. C. Frequently asked questions in drug combinations and the mass-action law-based answers. Synergy 1:3-21, 2014 (The frist article in inaugural issue)

  4. For Econo-Green Bio-Research:
    • Chou, T.-C. The mass-action law based algorithm for quantitative econo-green bio-research. Integrative Biology 3: 548-559, 2011. (A Perspective Article)

    • Chou, T.-C. The mass-action law based algorithm for cost-effective approach for cancer drug discovery and development. Am J Cancer Res 1: 925-954, 2011 (A 30-page Review Article; www.ajcr.us/ISSN:2156-6976/ajcr0000077) [See P.943. Table 5 for FAQ]